Julieta Lazarte Selected Research

Vascular Diseases (Vascular Disease)

4/2022

Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julieta Lazarte Research Topics

Disease

4	Hypertriglyceridemia 06/2024 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 01/2020
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2022 - 01/2020
2	Inflammation (Inflammations) 01/2023 - 03/2015
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2021
2	Pancreatitis 09/2021 - 02/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2020
2	Dyslipidemias (Dyslipidemia) 02/2020 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 09/2016
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023
1	Genetic Risk Score 01/2023
1	Vascular Diseases (Vascular Disease) 04/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Lipodystrophy 09/2021
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 08/2021
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Myalgia 02/2021
1	Polymorphic catecholergic ventricular tachycardia 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Insulin Resistance 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Heart Failure 08/2018
1	Necrosis 03/2015

Drug/Important Bio-Agent (IBA)

6	Triglycerides (Triacylglycerol)IBA 06/2024 - 01/2020
5	LDL CholesterolIBA 04/2022 - 01/2020
3	LipidsIBA 04/2022 - 02/2020
3	HLA-G Antigens (HLA G)IBA 01/2020 - 09/2016
2	HDL CholesterolIBA 01/2021 - 02/2020
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2020 - 02/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 09/2016
1	evolocumabIBA 04/2022
1	oxidized low density lipoproteinIBA 04/2022
1	Ezetimibe (Zetia)FDA Link 04/2022
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2022
1	ISIS 304801IBA 08/2021
1	ApolipoproteinsIBA 08/2021
1	Antisense RNA (Anti-Sense RNA)IBA 08/2021
1	Apolipoprotein C-IIIIBA 08/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	CatecholaminesIBA 01/2021
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Antisense OligonucleotidesIBA 02/2020
1	Fibric Acids (Fibrates)IBA 02/2020
1	Monoclonal AntibodiesIBA 02/2020
1	Lipoprotein(a)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 03/2015
1	Interleukin-8 (Interleukin 8)IBA 03/2015
1	Chemokine CCL22IBA 03/2015

Therapy/Procedure

2	Therapeutics 04/2022 - 02/2020
1	Lung Transplantation 01/2023
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2023
1	Deprescriptions 04/2022
1	Immunotherapy 01/2020
1	Transplantation 09/2016
1	Heart Transplantation (Grafting, Heart) 09/2016
1	Heart-Assist Devices 03/2015